On the public citation graph
Challenges and Future Trends in the Treatment of Psoriasis
0 signed · 393 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.2020.4006openalex-snapshot
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
inferredcites →https://doi.org/10.1001/jamadermatol.2015.0718openalex-snapshot
Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis
inferredcites →https://doi.org/10.1001/jamadermatol.2019.4029openalex-snapshot
Comparison of Biologics and Oral Treatments for Plaque Psoriasis
inferredcites →https://doi.org/10.1001/jamadermatol.2020.0723openalex-snapshot
Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis
inferredcites →https://doi.org/10.1002/14651858.cd010227.pub2openalex-snapshot
Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis: A network meta-analysis
inferredcites →https://doi.org/10.1007/s00403-010-1080-1openalex-snapshot
Definition of treatment goals for moderate to severe psoriasis: a European consensus
inferredcites →https://doi.org/10.1007/s12326-018-0279-3openalex-snapshot
308 nm-Excimerlaser zur Therapie von Psoriasis und entzündlichen Hauterkrankungen
inferredcites →https://doi.org/10.1007/s13555-017-0198-xopenalex-snapshot
Long-Term Safety and Effectiveness of Adalimumab for Moderate to Severe Psoriasis: Results from 7-Year Interim Analysis of the ESPRIT Registry
inferredcites →https://doi.org/10.1007/s13555-023-00903-5openalex-snapshot
Combination Therapy for Psoriasis with Methotrexate and Other Oral Disease-Modifying Antirheumatic Drugs: A Systematic Review
inferredcites →https://doi.org/10.1007/s40257-014-0097-1openalex-snapshot
Use of Biologic Agents in Combination with Other Therapies for the Treatment of Psoriasis
inferredcites →https://doi.org/10.1007/s40257-019-00447-5openalex-snapshot
Genital Psoriasis: Impact on Quality of Life and Treatment Options
inferredcites →https://doi.org/10.1007/s40257-020-00503-5openalex-snapshot
Palmoplantar Pustulosis: Recent Advances in Etiopathogenesis and Emerging Treatments
inferredcites →https://doi.org/10.1007/s40257-022-00703-1openalex-snapshot
Combination Therapy with Apremilast and Biologics for Psoriasis: A Systematic Review
inferredcites →https://doi.org/10.1016/j.actbio.2020.12.004openalex-snapshot
Microneedle-mediated transdermal drug delivery for treating diverse skin diseases
inferredcites →https://doi.org/10.1016/j.colsurfb.2016.01.021openalex-snapshot
Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis
inferredcites →https://doi.org/10.1016/j.ijpharm.2015.03.020openalex-snapshot
Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: Application of Box–Behnken design, in-vitro evaluation and in-vivo skin deposition study
inferredcites →https://doi.org/10.1016/j.ijpharm.2018.11.032openalex-snapshot
Biocompatible nanoparticles and vesicular systems in transdermal drug delivery for various skin diseases
inferredcites →https://doi.org/10.1016/j.jaad.2014.08.050openalex-snapshot
OBSERVE-5: Observational postmarketing safety surveillance registry of etanercept for the treatment of psoriasis final 5-year results
inferredcites →https://doi.org/10.1016/j.jaad.2016.10.027openalex-snapshot
Inflammatory bowel disease among patients with psoriasis treated with ixekizumab: A presentation of adjudicated data from an integrated database of 7 randomized controlled and uncontrolled trials
inferredcites →https://doi.org/10.1016/j.jaad.2018.03.040openalex-snapshot
Safety and efficacy of a fixed combination of halobetasol and tazarotene in the treatment of moderate-to-severe plaque psoriasis: Results of 2 phase 3 randomized controlled trials
inferredcites →https://doi.org/10.1016/j.jaad.2018.06.057openalex-snapshot
Psoriasis: Which therapy for which patient
inferredcites →https://doi.org/10.1016/j.jaad.2018.11.057openalex-snapshot
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics
inferredcites →https://doi.org/10.1016/j.jaad.2019.04.042openalex-snapshot
Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy
inferredcites →https://doi.org/10.1016/j.jaad.2020.02.044openalex-snapshot
Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies
inferredcites →https://doi.org/10.1016/j.jaad.2020.07.087openalex-snapshot
Joint AAD–NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures
inferredcites →https://doi.org/10.1016/j.jaad.2021.06.869openalex-snapshot
Tyrosine kinase 2 and Janus kinase‒signal transducer and activator of transcription signaling and inhibition in plaque psoriasis
inferredcites →https://doi.org/10.1016/j.jaad.2022.08.061openalex-snapshot
Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr Evaluation of TYK2 inhibitor psoriasis second trial
inferredcites →https://doi.org/10.1016/j.jaci.2014.09.043openalex-snapshot
IL36RN mutations define a severe autoinflammatory phenotype of generalized pustular psoriasis
inferredcites →https://doi.org/10.1016/j.jid.2016.08.034openalex-snapshot
Infections in Moderate to Severe Psoriasis Patients Treated with Biological Drugs Compared to Classic Systemic Drugs: Findings from the BIOBADADERM Registry
inferredcites →https://doi.org/10.1016/j.jid.2019.09.018openalex-snapshot
Nanoparticle-Coupled Topical Methotrexate Can Normalize Immune Responses and Induce Tissue Remodeling in Psoriasis
inferredcites →https://doi.org/10.1016/s0190-9622(97)70281-0openalex-snapshot
Topical calcipotriol in childhood psoriasis
inferredcites →https://doi.org/10.1021/acs.jmedchem.8b00588openalex-snapshot
Combating Autoimmune Diseases With Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc) Inhibitors: Hits and Misses
inferredcites →https://doi.org/10.1021/acsami.9b15668openalex-snapshot
Hyaluronic Acid-Based Dissolving Microneedle Patch Loaded with Methotrexate for Improved Treatment of Psoriasis
inferredcites →https://doi.org/10.1038/s41598-019-45626-wopenalex-snapshot
Small Molecule IL-36γ Antagonist as a Novel Therapeutic Approach for Plaque Psoriasis
inferredcites →https://doi.org/10.1039/d2tb00614fopenalex-snapshot
Latest on biomaterial-based therapies for topical treatment of psoriasis
inferredcites →https://doi.org/10.1080/09546634.2021.1966357openalex-snapshot
Soluble biomarkers for diagnosis, monitoring, and therapeutic response assessment in psoriasis
inferredcites →https://doi.org/10.1080/09546634.2023.2200870openalex-snapshot
Real-world switching patterns and associated characteristics in patients with psoriasis treated with biologics in the United States
inferredcites →https://doi.org/10.1080/14712598.2019.1579794openalex-snapshot
Brodalumab for the treatment of plaque psoriasis: up-to-date
inferredcites →https://doi.org/10.1093/bjd/ljac049openalex-snapshot
Spesolimab in the treatment of generalized pustular psoriasis: a critically appraised research paper
inferredcites →https://doi.org/10.1111/1346-8138.13860openalex-snapshot
Switching of biologics in psoriasis: Reasons and results
inferredcites →https://doi.org/10.1111/bcp.15101openalex-snapshot
Switching between reference adalimumab and biosimilars in chronic immune‐mediated inflammatory diseases: A systematic literature review
inferredcites →https://doi.org/10.1111/bjd.15779openalex-snapshot
A hyaluronic acid‐based microneedle patch to treat psoriatic plaques: a pilot open trial
inferredcites →https://doi.org/10.1111/bjd.16050openalex-snapshot
Ixekizumab treatment for psoriasis: integrated efficacy analysis of three double-blinded, controlled studies (UNCOVER-1, UNCOVER-2, UNCOVER-3)
inferredcites →https://doi.org/10.1111/bjd.16102openalex-snapshot
Safety, efficacy and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasis
inferredcites →https://doi.org/10.1111/bjd.20517openalex-snapshot
The promise and challenges of cell therapy for psoriasis*
inferredcites →https://doi.org/10.1111/bjd.21627openalex-snapshot
Biomarkers of disease progression in people with psoriasis: a scoping review
inferredcites →https://doi.org/10.1111/bjd.21743openalex-snapshot
Efficacy and safety of mirikizumab in psoriasis: results from a 52-week, double-blind, placebo-controlled, randomized withdrawal, phase III trial (OASIS-1)
inferredcites →https://doi.org/10.1111/dth.15364openalex-snapshot
Proactive therapy: New perspectives for long‐term topical treatment of psoriasis
inferredcites →https://doi.org/10.1111/exd.13707openalex-snapshot
Topical silver and gold nanoparticles complexed with Cornus mas suppress inflammation in human psoriasis plaques by inhibiting NF ‐κB activity
inferredcites →https://doi.org/10.1111/ijd.12790openalex-snapshot
The role of vitamin D in psoriasis: a review
inferredcites →https://doi.org/10.1111/j.1365-2133.2010.09999.xopenalex-snapshot
Switching biologics for psoriasis
inferredcites →https://doi.org/10.1111/j.1468-3083.2012.04585.xopenalex-snapshot
Induction phase, primary endpoint, time to decide on primary failure, and therapeutic goals in biologic treatment of psoriasis
inferredcites →https://doi.org/10.1111/jdv.14949openalex-snapshot
Generalized pustular psoriasis: a review and update on treatment
inferredcites →https://doi.org/10.1111/jdv.16684openalex-snapshot
Practical recommendations for systemic treatment in psoriasis according to age, pregnancy, metabolic syndrome, mental health, psoriasis subtype and treatment history (BETA‐PSO: Belgian Evidence‐based Treatment Advice in Psoriasis; part 1)
inferredcites →https://doi.org/10.1111/jdv.18263openalex-snapshot
The efficacy and safety of tofacitinib, peficitinib, solcitinib, baricitinib, abrocitinib and deucravacitinib in plaque psoriasis – A network meta‐analysis
inferredcites →https://doi.org/10.1126/sciadv.abe2888openalex-snapshot
Microneedle-assisted genome editing: A transdermal strategy of targeting NLRP3 by CRISPR-Cas9 for synergistic therapy of inflammatory skin disorders
inferredcites →https://doi.org/10.1159/000504839openalex-snapshot
Switching Biologics in the Treatment of Psoriasis: A Multicenter Experience
inferredcites →https://doi.org/10.1159/000512930openalex-snapshot
Topical Treatment of Psoriasis Vulgaris: The Swiss Treatment Pathway
inferredcites →https://doi.org/10.1186/s43094-021-00324-1openalex-snapshot
Nanofiber as a novel vehicle for transdermal delivery of therapeutic agents: challenges and opportunities
inferredcites →https://doi.org/10.1586/1744666x.2015.1095092openalex-snapshot
Secukinumab (AIN457) for the treatment of psoriasis
inferredcites →https://doi.org/10.2174/1389450122666210118103455openalex-snapshot
Recent Advances in Psoriasis Therapy: Trends and Future Prospects
inferredcites →https://doi.org/10.2310/7750.2009.09007openalex-snapshot
Drug-Induced Hepatitis and Lupus during Infliximab Treatment for Psoriasis: Case Report and Literature Review
inferredcites →https://doi.org/10.2340/00015555-3386openalex-snapshot
Psoriasis and Treatment: Past, Present and Future Aspects
inferredcites →https://doi.org/10.2340/actadv.v103.6525openalex-snapshot
Safety and Efficacy of Topical Calcineurin Inhibitors in the Treatment of Facial and Genital Psoriasis: A Systematic Review
inferredcites →https://doi.org/10.25259/ijdvl_308_2022openalex-snapshot
Review of the reasons for and effectiveness of switching biologics for psoriasis treatment in Korea
inferredcites →https://doi.org/10.3389/fimmu.2018.01210openalex-snapshot
Transcription Factor Retinoid-Related Orphan Receptor γt: A Promising Target for the Treatment of Psoriasis
inferredcites →https://doi.org/10.3389/fimmu.2020.01855openalex-snapshot
Multifactorial Design of a Supramolecular Peptide Anti-IL-17 Vaccine Toward the Treatment of Psoriasis
inferredcites →https://doi.org/10.3390/ijms20133318openalex-snapshot
The Significance of IL-36 Hyperactivation and IL-36R Targeting in Psoriasis
inferredcites →https://doi.org/10.3390/ijms22158076openalex-snapshot
Mast Cell Cytokines IL-1, IL-33, and IL-36 Mediate Skin Inflammation in Psoriasis: A Novel Therapeutic Approach with the Anti-Inflammatory Cytokines IL-37, IL-38, and IL-1Ra
inferredcites →https://doi.org/10.3390/life11070627openalex-snapshot
A New Classification of the Severity of Psoriasis: What’s Moderate Psoriasis?
inferredcites →https://doi.org/10.3390/molecules24071388openalex-snapshot
Synergistic Effects of Photo-Irradiation and Curcumin-Chitosan/Alginate Nanoparticles on Tumor Necrosis Factor-Alpha-Induced Psoriasis-Like Proliferation of Keratinocytes
inferredcites →https://doi.org/10.4049/jimmunol.1602142openalex-snapshot
Cutting Edge: Selective Oral ROCK2 Inhibitor Reduces Clinical Scores in Patients with Psoriasis Vulgaris and Normalizes Skin Pathology via Concurrent Regulation of IL-17 and IL-10
inferredcites →https://doi.org/10.7573/dic.212570openalex-snapshot
Brodalumab in psoriasis: evidence to date and clinical potential
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.3897/pharmacia.73.e181735zenodo-depositor-declared
Therapeutic drug monitoring for optimizing ustekinumab therapy in Iraqi patients with psoriasis: A real-world study
inferred← citeshttps://doi.org/10.1002/adhm.202503806openalex-snapshot
Advances in Bioprinting to Model Immune‐Mediated Skin Diseases
inferred← citeshttps://doi.org/10.1002/advs.202409359openalex-snapshot
Dual‐Action Psoriasis Therapy: Antiproliferative and Immunomodulatory Effects via Self‐Locking Microneedles
inferred← citeshttps://doi.org/10.1002/aisy.202400558openalex-snapshot
Integrating Artificial Intelligence and Microfluidics Technology for Psoriasis Therapy: A Comprehensive Review for Research and Clinical Applications
inferred← citeshttps://doi.org/10.1002/ardp.202400410openalex-snapshot
Green preparation and evaluation of the anti‐psoriatic activity of vesicular elastic nanocarriers of kojic acid from Aspergillus oryzae N12: Repurposing of a dermo‐cosmetic lead
inferred← citeshttps://doi.org/10.1002/ddr.70213openalex-snapshot
Interface‐Engineered Nanocarriers for Translational and Patient‐Centric Topical Therapy in Psoriasis
inferred← citeshttps://doi.org/10.1002/hsr2.72524openalex-snapshot
Nanotechnology in Dermatology: A Comprehensive Narrative Review of Performance, Safety, and Clinical Translation
inferred← citeshttps://doi.org/10.1002/iid3.1303openalex-snapshot
Wogonin ameliorates the proliferation, inflammatory response, and pyroptosis in keratinocytes via NOD‐like receptor family pyrin domain containing 3/Caspase‐1/Gasdermin‐D pathway
inferred← citeshttps://doi.org/10.1002/iid3.70211openalex-snapshot
The M2 Macrophages Importance Role in Psoriasis
inferred← citeshttps://doi.org/10.1002/jcla.70203openalex-snapshot
Experimental Validation of an Immune Cell Infiltration Signature in Psoriasis: Translating Computational Modeling to In Vivo Efficacy
inferred← citeshttps://doi.org/10.1002/mabi.202400607openalex-snapshot
Polyphenol Microneedles for Dermatological Therapy
inferred← citeshttps://doi.org/10.1002/ptr.70085openalex-snapshot
Harnessing Natural Compounds in Psoriasis: Targeting Cellular Pathways for Effective Therapy
inferred← citeshttps://doi.org/10.1002/ptr.70342openalex-snapshot
Gentiopicroside Ameliorates Psoriasis‐Like Dermatitis by Modulating Immune Homeostasis and Suppressing NF ‐ κB Activation
inferred← citeshttps://doi.org/10.1002/viw2.70194openalex-snapshot
Plant‐derived nanovesicles as potential drug delivery systems for topical use: Emerging applications in dermatology and cosmetology
inferred← citeshttps://doi.org/10.1007/978-3-031-78139-1_3openalex-snapshot
The Role of Artificial Intelligence in Psoriasis
inferred← citeshttps://doi.org/10.1007/978-981-95-7490-2_12openalex-snapshot
Recent Advancements in Topical Drug Delivery Systems in the Management of Psoriasis
inferred← citeshttps://doi.org/10.1007/s00011-026-02245-2openalex-snapshot
Tm4sf19 inhibition alleviates imiquimod-induced psoriatic dermatitis by regulating inflammatory signaling pathways and keratinocyte proliferation in mice
inferred← citeshttps://doi.org/10.1007/s00210-025-04334-1openalex-snapshot
Balancing efficacy and hepatotoxicity: a comprehensive review of oral medications in psoriasis management
inferred← citeshttps://doi.org/10.1007/s00210-025-04490-4openalex-snapshot
Comparison of patient-reported outcomes in patients achieving complete versus near-complete skin clearance following Vunakizumab treatment: a post-hoc analysis of a phase III trial
inferred← citeshttps://doi.org/10.1007/s00210-025-04911-4openalex-snapshot
Efficacy and safety of vunakizumab between super responders and non-super responders of patients with moderate-to-severe plaque psoriasis: a post-hoc exploratory analysis of a phase III trial
inferred← citeshttps://doi.org/10.1007/s00228-025-03986-5openalex-snapshot
A review of current therapeutics for psoriasis: Systemic and topical use of non-biological drugs
inferred← citeshttps://doi.org/10.1007/s00403-025-04097-yopenalex-snapshot
Therapeutic potential of microbiota modulation in psoriasis: current evidence and future directions
inferred← citeshttps://doi.org/10.1007/s00403-026-04614-7openalex-snapshot
Immunopathology of psoriasis: a focus on TH17/Treg dynamics & their potential impact on disease recurrence
inferred← citeshttps://doi.org/10.1007/s10068-025-01894-zopenalex-snapshot
Therapeutic potential of phytochemical luteolin in restoring skin barrier by inhibiting antimicrobial peptides associated with TRAF6/TAK1/IKK/IκB in psoriasis-like HaCaT models
inferred← citeshttps://doi.org/10.1007/s10103-024-04005-2openalex-snapshot
Excimer light effect on neurogenic inflammation in active versus stable psoriasis lesions
inferred← citeshttps://doi.org/10.1007/s10462-024-11031-7openalex-snapshot
A comprehensive study on the application of machine learning in psoriasis diagnosis and treatment: taxonomy, challenges and recommendations
inferred← citeshttps://doi.org/10.1007/s10528-024-10680-1openalex-snapshot
Daturataturin A Ameliorates Psoriasis by Regulating PPAR Pathway
inferred← citeshttps://doi.org/10.1007/s10787-025-01658-5openalex-snapshot
Efficacy and safety of mirikizumab in psoriasis: a systematic review and meta-analysis of randomized controlled trials
inferred← citeshttps://doi.org/10.1007/s10787-025-02027-yopenalex-snapshot
Psoriasis beyond the skin: systemic inflammation as a bridge to metabolic and hepatic comorbidities
inferred← citeshttps://doi.org/10.1007/s10787-025-02095-0openalex-snapshot
Role of transient receptor potential channels on pathogenesis and treatment of psoriasis
inferred← citeshttps://doi.org/10.1007/s11255-026-05299-7openalex-snapshot
Psoriasis and chronic kidney disease: insights into mechanisms and novel therapeutic outlooks
inferred← citeshttps://doi.org/10.1007/s11418-026-02015-8openalex-snapshot
Olive (Olea europaea) phenolics for the control of psoriasis via targeting SMYD2 and IL-17A protein–protein interaction networks
inferred← citeshttps://doi.org/10.1007/s12026-025-09635-4openalex-snapshot
Assessment of antipsoriatic potential of novel pemetrexed disodium–loaded transdermal patches in an imiquimod-induced mouse model
inferred← citeshttps://doi.org/10.1007/s12247-025-09997-0openalex-snapshot
Application of Analytical Hierarchy Process to the Selection Suitability of Biological Drug forms for Psoriasis Treatment
inferred← citeshttps://doi.org/10.1007/s12247-026-10726-4openalex-snapshot
Exploring the Potential of Topical Praziquantel-loaded Ethosomal Gel for the Management of Psoriasis: In vitro and In vivo Assessment
inferred← citeshttps://doi.org/10.1007/s12247-026-10903-5openalex-snapshot
Sphingosine-1-Phosphate Signaling and Nanocarrier-Based Topical Therapeutics in Plaque Psoriasis
inferred← citeshttps://doi.org/10.1007/s12325-024-03034-1openalex-snapshot
Comparative Effectiveness of Biologic Classes in Clinical Practice: Month 12 Outcomes from the International Observational Psoriasis Study of Health Outcomes (PSoHO)
inferred← citeshttps://doi.org/10.1007/s12529-025-10405-7openalex-snapshot
Associations of Healthy Sleep Patterns with Psoriasis Risk: Insights from a Longitudinal Cohort Study
inferred← citeshttps://doi.org/10.1007/s12668-025-02080-5openalex-snapshot
Budesonide-Loaded Solid Lipid Nanoparticle Engrossed Hydrogel: Statistical Optimization, Improved Penetration, Skin Deposition and Dermal Targeting for Preclinical Assessment of psoriatic lesions
inferred← citeshttps://doi.org/10.1007/s12668-025-02338-yopenalex-snapshot
pH Responsive Trimethyl Chitosan Nanogels Enhance Site-Specific Fluocinolone Acetonide Delivery for Psoriasis Therapy
inferred← citeshttps://doi.org/10.1007/s13204-025-03101-1openalex-snapshot
Assessing the potential of metallic nanocarriers as theranostics for psoriasis management: a comprehensive review
inferred← citeshttps://doi.org/10.1007/s13346-024-01705-8openalex-snapshot
Choline-based ionic liquids enhance the dermal delivery of cyclosporine a for potential treatment of psoriasis
inferred← citeshttps://doi.org/10.1007/s13346-025-01800-4openalex-snapshot
Topical delivery of siRNA to psoriatic skin model using high molecular weight chitosan derivatives: In vitro and in vivo studies
inferred← citeshttps://doi.org/10.1007/s13346-025-02016-2openalex-snapshot
Dual drug co-encapsulation into liposomes and liposome-derived nanosystems for improved synergistic treatment of skin diseases
inferred← citeshttps://doi.org/10.1007/s13555-026-01851-6openalex-snapshot
Understanding Social Drivers of Health Among US Adults with Psoriasis from Different Races and Ethnicities
inferred← citeshttps://doi.org/10.1007/s40257-025-00928-wopenalex-snapshot
Next-Generation Anti-IL-17 Agents for Psoriatic Disease: A Pipeline Review
inferred← citeshttps://doi.org/10.1007/s40519-025-01762-zopenalex-snapshot
Exploring the relationship between novel measurements of abdominal obesity and psoriasis: a cross-sectional study from the NHANES database
inferred← citeshttps://doi.org/10.1007/s40883-026-00629-8openalex-snapshot
Nanocarrier-based Herbal Topical Delivery Systems: Recent Progress in Psoriasis Treatment
inferred← citeshttps://doi.org/10.1007/s43630-025-00837-1openalex-snapshot
Narrowband-UVB may restore adalimumab efficacy in chronic plaque psoriasis patients: A prospective exploratory cohort study
inferred← citeshttps://doi.org/10.1007/s44174-025-00483-2openalex-snapshot
Liposomes and Niosomes in Psoriasis Therapy: Emerging Vesicular Approaches for Targeted Treatment
inferred← citeshttps://doi.org/10.1007/s44395-025-00029-xopenalex-snapshot
Exploring innovative therapeutic strategies for psoriasis treatment using bioactive compounds
inferred← citeshttps://doi.org/10.1016/b978-0-443-36326-9.00017-4openalex-snapshot
Integrating nanotechnology in clinical management of dermatological conditions—The need of modern health care
inferred← citeshttps://doi.org/10.1016/j.abd.2025.501132openalex-snapshot
Predictors of PASI90 response in patients with psoriasis treated with ınterleukin ınhibitors: observational cohort study
inferred← citeshttps://doi.org/10.1016/j.abd.2025.501156openalex-snapshot
Use of ustekinumab in the treatment of severe psoriasis in a liver transplant recipient
inferred← citeshttps://doi.org/10.1016/j.abdp.2025.501132openalex-snapshot
Preditores da resposta PASI90 em pacientes com psoríase tratados com inibidores de interleucina: estudo de coorte observacional
inferred← citeshttps://doi.org/10.1016/j.abdp.2025.501156openalex-snapshot
Uso de ustequinumabe no tratamento de psoríase grave em receptor de transplante de fígado
inferred← citeshttps://doi.org/10.1016/j.actbio.2025.04.015openalex-snapshot
Drug-loaded microneedle patches containing regulatory T cell-derived exosomes for psoriasis treatment
inferred← citeshttps://doi.org/10.1016/j.ajps.2025.101062openalex-snapshot
Celastrol-loaded metal-phenolic nanozymes integrated microneedles with ROS scavenging and anti-inflammatory activities for psoriasis treatment
inferred← citeshttps://doi.org/10.1016/j.apmt.2024.102278openalex-snapshot
Designing biomaterials for the treatment of autoimmune diseases
inferred← citeshttps://doi.org/10.1016/j.apsb.2024.02.002openalex-snapshot
Spirohypertones A and B as potent antipsoriatics: Tumor necrosis factor-α inhibitors with unprecedented chemical architectures
inferred← citeshttps://doi.org/10.1016/j.bbi.2024.10.031openalex-snapshot
An initial investigation of transcutaneous delivery of plasmid DNA encoding interleukin-10 for the treatment of psoriatic skin conditions
inferred← citeshttps://doi.org/10.1016/j.bbrc.2024.150740openalex-snapshot
Multi-omic analysis revealed the immunological patterns and diagnostic value of exhausted T cell-derived PTTG1 in patients with psoriasis
inferred← citeshttps://doi.org/10.1016/j.bioadv.2025.214259openalex-snapshot
Fire cupping inspired negative-pressure microneedle syringes loaded with herb berberine-based nano composite for psoriasis therapy
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2025.123882openalex-snapshot
In silico optimized cell-penetrating peptides achieve transdermal siRNA delivery and regulate inflammatory environment in psoriasis
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2026.124697openalex-snapshot
Microneedle-Guided Ultraviolet Phototherapy with Local Calcipotriol Delivery for Enhanced Psoriasis Treatment
inferred← citeshttps://doi.org/10.1016/j.bioorg.2025.108711openalex-snapshot
Benzoylpaeoniflorin alleviates psoriasis-like inflammation by modulating immune balance and inhibiting NF-κB signaling pathway
inferred← citeshttps://doi.org/10.1016/j.biopha.2025.117910openalex-snapshot
The fungal protein Lingzhi-8 ameliorates psoriasis-like dermatitis in mice through gut CD103+ tolerogenic dendritic cells, retinaldehyde dehydrogenase 2, and Dectin-1
inferred← citeshttps://doi.org/10.1016/j.ccr.2026.218101openalex-snapshot
Novel photoactive agents based on phthalocyanines conjugated to targeting vectors: trends and challenges
inferred← citeshttps://doi.org/10.1016/j.cej.2024.157293openalex-snapshot
Efficient extraction of interstitial fluid using an ultrasonic-powered replaceable hexagram-shaped hydrogel microneedle patch for monitoring of dermal pharmacokinetics and psoriatic biomarkers
inferred← citeshttps://doi.org/10.1016/j.cellsig.2024.111171openalex-snapshot
Upregulated miR-374a-5p drives psoriasis pathogenesis through WIF1 downregulation and Wnt5a/NF-κB activation
inferred← citeshttps://doi.org/10.1016/j.clinthera.2025.06.017openalex-snapshot
Effects of Vunakizumab Treatment on Detailed Dimensions of Patient-Reported Outcomes in Moderate-to-Severe Plaque Psoriasis Patients: A Post-Hoc Analysis of a Randomized Controlled Trial (NCT04839016)
inferred← citeshttps://doi.org/10.1016/j.colsurfb.2025.114984openalex-snapshot
Study on the absorption mechanism of glucocorticoids in the stratum corneum
inferred← citeshttps://doi.org/10.1016/j.cyto.2025.157078openalex-snapshot
FOXC1 ameliorates the disease progression of psoriasis through transcriptional upregulation of SOCS3
inferred← citeshttps://doi.org/10.1016/j.ejmech.2025.117904openalex-snapshot
Small molecular inhibitors targeting Janus kinases (JAKs) for the treatment of psoriasis
inferred← citeshttps://doi.org/10.1016/j.ejphar.2024.177011openalex-snapshot
Topical histone deacetylase inhibitor remetinostat improves IMQ-induced psoriatic dermatitis via suppressing dendritic cell maturation and keratinocyte differentiation and inflammation
inferred← citeshttps://doi.org/10.1016/j.ejphar.2025.177330openalex-snapshot
Cathelicidin-HG alleviates psoriasis by targeting glycoprotein VI to inhibit platelet-neutrophil complexes formation
inferred← citeshttps://doi.org/10.1016/j.ejphar.2025.177921openalex-snapshot
Hydroxypropyl-β-cyclodextrin inclusion complex improves the percutaneous therapeutic effect of eugenol on psoriasis mice
inferred← citeshttps://doi.org/10.1016/j.ejps.2026.107429openalex-snapshot
Development and in vitro/in vivo evaluation of polymeric dissolving microneedle formulation for psoriasis treatment
inferred← citeshttps://doi.org/10.1016/j.humimm.2024.111161openalex-snapshot
Decoy oligodeoxynucleotides: A promising therapeutic strategy for inflammatory skin disorders
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2025.125385openalex-snapshot
A new era of psoriasis treatment: Drug repurposing through the lens of nanotechnology and machine learning
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2025.126000openalex-snapshot
Mitochondria-targeted curcumin microneedles for psoriasis therapy via autophagy activation and epidermal hyperplasia suppression
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2025.126283openalex-snapshot
Integrated experimental, computational and machine learning approaches for the development of Apremilast-Aceclofenac coamorphous systems
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2026.126603openalex-snapshot
Ionic liquids in dermatological drug delivery: advances, mechanisms, and therapeutic potential
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2026.127348openalex-snapshot
Advanced drug delivery systems for topical treatment of common skin diseases: a decade in review
inferred← citeshttps://doi.org/10.1016/j.ijpx.2025.100397openalex-snapshot
recent advances in the pathogenesis of vitiligo and the application of novel drug delivery systems in its treatment
inferred← citeshttps://doi.org/10.1016/j.intimp.2024.112033openalex-snapshot
Decreased HMGCS1 inhibits proliferation and inflammatory response of keratinocytes and ameliorates imiquimod-induced psoriasis via the STAT3/IL-23 axis
inferred← citeshttps://doi.org/10.1016/j.intimp.2024.112225openalex-snapshot
Long-term therapy with itolizumab is safe and effective for patients with moderate to severe psoriasis: Results from an expanded-access program
inferred← citeshttps://doi.org/10.1016/j.intimp.2024.113508openalex-snapshot
From Manifestations to Innovations: A Deep Dive into Psoriasis, its Clinical Diversity, Conventional Treatments, and Emerging Therapeutic Paradigms
inferred← citeshttps://doi.org/10.1016/j.intimp.2025.114036openalex-snapshot
Knockdown of GSDMD inhibits pyroptosis in psoriasis by blocking the NOD-like receptor signaling pathway
inferred← citeshttps://doi.org/10.1016/j.intimp.2025.115429openalex-snapshot
Advancing insights into psoriasis: from pathogenesis to current and emerging therapies
inferred← citeshttps://doi.org/10.1016/j.intimp.2026.116161openalex-snapshot
Efficacy and safety of vunakizumab in patients with moderate-to-severe plaque psoriasis who have a history of systemic therapies: a post hoc analysis of a phase III trial
inferred← citeshttps://doi.org/10.1016/j.jare.2024.07.026openalex-snapshot
Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
inferred← citeshttps://doi.org/10.1016/j.jconrel.2025.114218openalex-snapshot
Novel TNF-α-targeting mRNA therapy for sustained psoriasis treatment and relapse prevention by suppressing IL-15-TRM signaling
inferred← citeshttps://doi.org/10.1016/j.jddst.2024.106521openalex-snapshot
Brucine-Loaded Nickel oxide/Sodium alginate/Polyethylene glycol Nanocomposites Mitigates Inflammatory Responses and Oxidative stress in imiquimod-induced Psoriasis-Like Skin Inflammation in Mice
inferred← citeshttps://doi.org/10.1016/j.jddst.2025.107444openalex-snapshot
Metal-organic frameworks for microneedles: Bridging the gap between nanomaterials and transdermal therapeutics
inferred← citeshttps://doi.org/10.1016/j.jddst.2025.107681openalex-snapshot
Statistically optimized, apigenin loaded ultra-deformable liposomes for the management of imiquimod induced psoriasis in mice model
inferred← citeshttps://doi.org/10.1016/j.jep.2024.117856openalex-snapshot
Evaluating the efficacy and mechanisms of Hua-Zhuo-Ning-Fu-Decoction on psoriasis using integrated bioinformatics analysis and metabolomics
inferred← citeshttps://doi.org/10.1016/j.medmic.2025.100126openalex-snapshot
The gut-skin axis in psoriasis: Evidence-based insights from a meta-analysis on probiotics-synbiotics-mediated microbiota interventions
inferred← citeshttps://doi.org/10.1016/j.micpath.2025.107572openalex-snapshot
Potential relationship between Helicobacter pylori infection and autoimmune disorders: A narrative review
inferred← citeshttps://doi.org/10.1016/j.mtbio.2025.102413openalex-snapshot
Selenium-functionalized hyaluronic acid dissolvable microneedle patch synergistic herbal shikonin-loaded tetrahedral framework nucleic acids for psoriasis therapy
inferred← citeshttps://doi.org/10.1016/j.nexres.2025.100731openalex-snapshot
Interplay of novel formulation-based treatment strategies for psoriasis: Advancing therapeutic outcomes
inferred← citeshttps://doi.org/10.1016/j.nexres.2026.102005openalex-snapshot
Nanostructured lipid carriers incorporated natural product: A promising approach for the managment of psoriasis
inferred← citeshttps://doi.org/10.1016/j.nxmate.2026.102209openalex-snapshot
Standardization and in vitro evaluation of in house developed anti-psoriatic ointment from traditional Unani formulation Zimad (Paste)
inferred← citeshttps://doi.org/10.1016/j.phymed.2025.156379openalex-snapshot
Exploring the therapeutic potential of Abelmoschi Corolla in psoriasis: Mechanisms of action and inflammatory pathway disruption
inferred← citeshttps://doi.org/10.1016/j.phymed.2025.157395openalex-snapshot
Guben-Qushi-Huayu formula and calycosin improve epidermal barrier function in psoriasis by inhibiting small proline-rich protein 1A
inferred← citeshttps://doi.org/10.1016/j.phymed.2025.157597openalex-snapshot
Biological activity study of a pine pollen extract rich in dihydroquercetin for the treatment of psoriasis
inferred← citeshttps://doi.org/10.1016/j.tice.2026.103861openalex-snapshot
Zhuhuang granules inhibit HIF-1α signaling to regulate oxidative stress-mitochondrial function axis to improve psoriasis
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.5c00647openalex-snapshot
Preparation and Evaluation of Upadacitinib-Loaded Binary Ethosomal Hydrogel: A Topical Delivery System with Enhanced Stratum Corneum Permeability for Improved Anti-Inflammatory Therapy in Psoriasis
inferred← citeshttps://doi.org/10.1021/acs.nanolett.5c02063openalex-snapshot
Circularization of Aptamer Nanomedicine Improves Nuclease Resistance, Targeted Recognition, and Transdermal Effect for Topical Psoriasis Therapy
inferred← citeshttps://doi.org/10.1021/acsabm.5c02234openalex-snapshot
Upconversion-Mediated Phototherapy for Psoriasis Treatment
inferred← citeshttps://doi.org/10.1021/acsptsci.5c00352openalex-snapshot
Harnessing Quinone Derivatives from Rubia cordifolia for Topical Therapy: Unveiling Structure–Activity and Structure–Permeation Relationships to Suppress Psoriasiform Inflammation
inferred← citeshttps://doi.org/10.1038/s12276-026-01738-8openalex-snapshot
RUNX1 recruitment of GCN5 in keratinocytes upregulates ICOSLG and promotes T cell activation in the psoriasis microenvironment
inferred← citeshttps://doi.org/10.1038/s41467-024-53396-xopenalex-snapshot
Sprayable inflammasome-inhibiting lipid nanorods in a polymeric scaffold for psoriasis therapy
inferred← citeshttps://doi.org/10.1038/s41598-024-65902-8openalex-snapshot
Reflectance confocal microscopy for plaque psoriasis therapeutic follow-up during an anti-interleukin-17A monoclonal antibody: an observational study
inferred← citeshttps://doi.org/10.1038/s41598-024-67350-wopenalex-snapshot
Unraveling shared molecular signatures and potential therapeutic targets linking psoriasis and acute myocardial infarction
inferred← citeshttps://doi.org/10.1038/s41598-025-21189-xopenalex-snapshot
The co-impact of diabetes and psoriasis on mortality risk for all causes and specific causes
inferred← citeshttps://doi.org/10.1038/s41598-025-90961-wopenalex-snapshot
Alloferon and IL-22 receptor expression regulation on the pathogenesis of imiquimod-induced psoriasis
inferred← citeshttps://doi.org/10.1038/s41598-026-47049-wopenalex-snapshot
Decoding cytokine interactions for psoriasis therapy through computational repurposing of antihypertensive drugs
inferred← citeshttps://doi.org/10.1039/d5bm01657fopenalex-snapshot
Two-dimensional GeTe nanosheets for psoriasis through modulation of macrophage activation and psoriatic inflammation
inferred← citeshttps://doi.org/10.1039/d5md01165eopenalex-snapshot
Design, synthesis and exploration of cyclic imides as PDE4 inhibitors in psoriasis
inferred← citeshttps://doi.org/10.1039/d5pm00173kopenalex-snapshot
Emerging smart microneedle technologies in psoriasis: convergence of nanocarriers, machine learning, and personalized delivery
inferred← citeshttps://doi.org/10.1039/d6nh00083eopenalex-snapshot
Transdermal drug delivery platform for psoriasis: co-delivery of methotrexate and TNF-α siRNA via hydrogel microneedles
inferred← citeshttps://doi.org/10.1055/a-2644-8732openalex-snapshot
Local and Systemic Effects of Topical Betulinic Acid in a Psoriasis-like Inflammation Model in Mice
inferred← citeshttps://doi.org/10.1080/00222348.2024.2358629openalex-snapshot
Macromolecular Biomaterials Endowed Strategies for Synergistic Treatment of Psoriasis: Recent Advancements and Future Prospects
inferred← citeshttps://doi.org/10.1080/09546634.2024.2420825openalex-snapshot
Effectiveness of tildrakizumab 200 mg: an Italian multicenter study
inferred← citeshttps://doi.org/10.1080/09546634.2025.2474505openalex-snapshot
The impact of a skin management model based on a precision quantitative ointment dispenser on skin symptoms and quality of life in elderly psoriasis patients
inferred← citeshttps://doi.org/10.1080/09546634.2025.2485254openalex-snapshot
Patient awareness and perspectives on psoriatic disease: results of the psoriasis and beyond survey from the Gulf region
inferred← citeshttps://doi.org/10.1080/09546634.2025.2604448openalex-snapshot
Efficacy and safety of cannabidiol oil in psoriasis: a randomized, double-blind, placebo-controlled trial
inferred← citeshttps://doi.org/10.1080/09546634.2026.2716564openalex-snapshot
Clinical predictors of early treatment response across systemic therapies in psoriasis: a prospective cohort study
inferred← citeshttps://doi.org/10.1080/1061186x.2025.2588692openalex-snapshot
Mupirocin-nanoemulsion infused salicylic acid gel utilizing nigella sativa oil for treatment of imiquimod-induced psoriasis in mice
inferred← citeshttps://doi.org/10.1080/14656566.2024.2373354openalex-snapshot
Novel pharmacotherapies and breakthroughs in psoriasis treatment: 2024 and beyond
inferred← citeshttps://doi.org/10.1080/14712598.2025.2495986openalex-snapshot
Review on recommendations on the use of biologic therapy for the management of moderate-severe psoriasis in Saudi Arabia: an expert opinion
inferred← citeshttps://doi.org/10.1080/14712598.2025.2576506openalex-snapshot
Comparative efficacy and safety of biosimilar Bmab 1200 versus reference ustekinumab in moderate-to-severe plaque psoriasis: 52-week findings from the Phase 3 STELLAR-2 trial
inferred← citeshttps://doi.org/10.1080/14740338.2024.2412221openalex-snapshot
Infection and infestation-related adverse events of biologics in psoriasis: insights from the Food and Drug Administration Adverse Event Reporting System (FAERS)
inferred← citeshttps://doi.org/10.1080/17425255.2024.2337749openalex-snapshot
Clinical pharmacokinetics and pharmacodynamics of topical non-biological therapies for psoriasis patients
inferred← citeshttps://doi.org/10.1080/17460441.2025.2507767openalex-snapshot
Small-molecule inhibitors in psoriasis: medicinal chemistry insights
inferred← citeshttps://doi.org/10.1080/17512433.2024.2340552openalex-snapshot
Choosing the right biologic treatment for moderate-to-severe plaque psoriasis: the impact of comorbidities
inferred← citeshttps://doi.org/10.1080/2314808x.2026.2715192openalex-snapshot
Efficacy of ethylmethylhydroxypyridine succinate in the experimental therapy of psoriasis-like dermatitis
inferred← citeshttps://doi.org/10.1093/bjd/ljae147openalex-snapshot
Insulin resistance impairs biologic agent response in moderate-to-severe plaque psoriasis: insights from a prospective cohort study in China
inferred← citeshttps://doi.org/10.1097/cm9.0000000000003799openalex-snapshot
Comprehensive management: Paradigm shift of care for psoriasis
inferred← citeshttps://doi.org/10.1097/md.0000000000047503openalex-snapshot
Causal relationships between psoriasis and coronary artery disease: A two-sample Mendelian randomization study
inferred← citeshttps://doi.org/10.1097/ms9.0000000000004427openalex-snapshot
Oral icotrokinra for plaque psoriasis in adults and adolescents
inferred← citeshttps://doi.org/10.1101/2025.02.28.640747openalex-snapshot
The inflammatory skin disease map (ISD map): an interactive computational resource focused on psoriasis and atopic dermatitis molecular mechanisms
inferred← citeshttps://doi.org/10.1101/2025.06.19.660481openalex-snapshot
TWEAK Signaling Drives the Transition from Psoriasis to Atopic Dermatitis-like Inflammation in Paradoxical Skin Reactions
inferred← citeshttps://doi.org/10.1101/2025.08.04.668478openalex-snapshot
Human Dermal Fibroblast-derived Spheroids Demonstrate Efficacious Immune Modulation in a Psoriasis Mouse Model
inferred← citeshttps://doi.org/10.1101/2025.08.06.668862openalex-snapshot
Autophagy maintains HEV identity and function during inflammation
inferred← citeshttps://doi.org/10.1101/2025.09.05.674535openalex-snapshot
TNFR2 is Expressed by a Discrete Subset of Epidermal γδ T Cells with an IL-17 Gene Signature during Psoriasis
inferred← citeshttps://doi.org/10.1111/1346-8138.17446openalex-snapshot
Bimekizumab efficacy and safety in Korean patients with moderate to severe plaque psoriasis: A phase 3, randomized, placebo‐controlled, double‐blinded study
inferred← citeshttps://doi.org/10.1111/ddg.16005openalex-snapshot
Widespread non‐blanching eruption in a female patient with recent fever on immunosuppressive therapy
inferred← citeshttps://doi.org/10.1111/ddg.16005_gopenalex-snapshot
Generalisierter, nicht verblassender Ausschlag bei einer Patientin mit kürzlich aufgetretenem Fieber unter immunsuppressiver Therapie
inferred← citeshttps://doi.org/10.1111/ddg.70306openalex-snapshot
Trust in skincare and topical therapies in atopic dermatitis or psoriasis: a German cross‐sectional study
inferred← citeshttps://doi.org/10.1111/exd.70317openalex-snapshot
Prevotella copri Exacerbates Psoriasis Through Keratinocyte‐Neutrophil Crosstalk via NF ‐ κB Activation
inferred← citeshttps://doi.org/10.1111/iej.14222openalex-snapshot
Association between apical periodontitis and psoriasis vulgaris: A cross‐sectional study
inferred← citeshttps://doi.org/10.1111/ijd.70371openalex-snapshot
Superior Clinical and Economic Value of IL ‐23 Inhibitors Versus Adalimumab Biosimilars in Plaque Psoriasis
inferred← citeshttps://doi.org/10.1111/imm.70099openalex-snapshot
Early Response to Vunakizumab at Week 2 Predicts Favourable Long‐Term Efficacy in Patients With Moderate‐To‐Severe Plaque Psoriasis: A Post Hoc Analysis of a Phase III , Randomised Controlled Trial
inferred← citeshttps://doi.org/10.1155/da/6275455openalex-snapshot
The Impact of Psoriasis Treatment on Depression and Suicide Risk: A Systematic Review
inferred← citeshttps://doi.org/10.1155/dth/2282045openalex-snapshot
Phospholipase A 2 Inhibitors as Potential Treatment of Psoriasis
inferred← citeshttps://doi.org/10.1155/dth/2672010openalex-snapshot
Effects of Oxymatrine on Epidermal Differentiation Complex–Related Genes in Psoriasis Patients
inferred← citeshttps://doi.org/10.1155/dth/3731758openalex-snapshot
Traditional Chinese Medicine Monomers for Psoriasis: Mechanistic Insights, Evidence, and Translational Perspectives
inferred← citeshttps://doi.org/10.1155/dth/6715205openalex-snapshot
Glucocorticoid Receptor Level as an Immunohistochemical Biomarker for Identification and Severity Assessment of Psoriasis and Its Association With Psoriasis Patients Complicated by Obesity and Hyperuricemia
inferred← citeshttps://doi.org/10.1155/dth/7466765openalex-snapshot
Marine‐Derived Biomaterials in Psoriasis Treatment: Therapeutic Potential and Development Perspectives
inferred← citeshttps://doi.org/10.1155/ijog/5132158openalex-snapshot
Cooling Blood and Detoxicating Formula Treats Psoriasis Through RHCG‐Related Mechanisms
inferred← citeshttps://doi.org/10.1155/mi/5063546openalex-snapshot
Tempol Ameliorates Psoriatic Skin Inflammation: Evidence of TLR4/NF‐κB/Nrf2 Axis Modulation
inferred← citeshttps://doi.org/10.1155/mi/9564209openalex-snapshot
Luteolin Disrupts Keratinocyte–Dendritic Cell Communication in Psoriasis by Targeting Rh Family C Glycoprotein
inferred← citeshttps://doi.org/10.1177/03000605261447159openalex-snapshot
Stellate ganglion block achieves remission of recurrent head-and-neck plaque psoriasis: A case report
inferred← citeshttps://doi.org/10.1177/03601293261446110openalex-snapshot
Tripterygium wilfordii Combined with Narrowband Ultraviolet B in the Treatment of Chronic Psoriasis: Synergistic Anti-Inflammatory Effect
inferred← citeshttps://doi.org/10.1177/20406223241230180openalex-snapshot
Real-world safety and effectiveness of secukinumab in adult patients with moderate to severe plaque psoriasis: results from postmarketing surveillance in Korea
inferred← citeshttps://doi.org/10.1177/2050313x241298884openalex-snapshot
Atypical presentation of psoriasis on the breast of an elderly woman: A case report
inferred← citeshttps://doi.org/10.1177/24755303261464171openalex-snapshot
Exploring the Gut Microbiome’s Association in Psoriasis and Psoriatic Arthritis: A Scoping Review
inferred← citeshttps://doi.org/10.1186/s10020-025-01253-yopenalex-snapshot
Paris saponin VII attenuates psoriasiform inflammation by regulating STAT3/NFκB signaling pathway and Caspase-1-induced pyroptosis
inferred← citeshttps://doi.org/10.1186/s11671-026-04727-yopenalex-snapshot
Nanotechnology based topical drug delivery systems for psoriasis addressing current strategies clinical progress and manufacturing challenges
inferred← citeshttps://doi.org/10.1186/s12865-024-00647-7openalex-snapshot
Pre-treatment plasma retinol binding protein 4 level and its change after treatments predict systemic treatment response in psoriasis patients
inferred← citeshttps://doi.org/10.1186/s12951-026-04264-xopenalex-snapshot
Hyaluronic acid-based reduction responsive nanoparticles for Improved anti-psoriasis effects of traditional Chinese herb monomer oleanolic acid via blocking YAP-AREG axis
inferred← citeshttps://doi.org/10.1186/s13568-025-01931-4openalex-snapshot
Therapeutic potential of recombinant IL-22BP in psoriasis: suppression of IL-22/STAT3 signaling in mice
inferred← citeshttps://doi.org/10.1186/s41065-025-00421-8openalex-snapshot
Application of bioinformatics analysis and molecular docking to study the mechanism of Qingying decoction in treating psoriasis
inferred← citeshttps://doi.org/10.1208/s12249-025-03098-4openalex-snapshot
Foam-Based Drug Delivery Systems for Skin Disorders: A Comprehensive Review
inferred← citeshttps://doi.org/10.1208/s12249-025-03179-4openalex-snapshot
Gallic Acid-Loaded Transethosomal Gel for Enhanced Topical Delivery and Sustained Therapeutic Efficacy in Psoriasis Management: Formulation, Optimization, In Vitro and Ex Vivo Assessment
inferred← citeshttps://doi.org/10.1208/s12249-025-03188-3openalex-snapshot
Exploring the Therapeutic Potential of Lipid Nanocarriers in Psoriasis Management: Advances and Applications
inferred← citeshttps://doi.org/10.12775/qs.2025.42.61118openalex-snapshot
The Role of Coenzyme Q10 Supplementation as a Potential Adjunct in the Treatment of Autoimmune Diseases
inferred← citeshttps://doi.org/10.12991/jrespharm.1763606openalex-snapshot
The role of microemulsion technology in psoriasis treatment: an evaluation in light of clinical and preclinical findings
inferred← citeshttps://doi.org/10.1371/journal.pone.0330939openalex-snapshot
Phytochemical and pharmacoinformatics analysis of a traditional antipsoriatic oil formulation for its potential against proinflammatory cytokines TNF-α and IL-17A
inferred← citeshttps://doi.org/10.1371/journal.pone.0351508openalex-snapshot
TNFR2 is expressed by a discrete subset of epidermal T cells with an IL-17 gene signature during psoriasis
inferred← citeshttps://doi.org/10.1515/jcim-2025-0057openalex-snapshot
Chronic toxicity and modulatory effects of Deprungsith formulation in Wistar Albino rats
inferred← citeshttps://doi.org/10.1515/znc-2024-0118openalex-snapshot
Advancing psoriasis drug delivery through topical liposomes
inferred← citeshttps://doi.org/10.1515/znc-2024-0153openalex-snapshot
Phyto-pharmaceuticals as a safe and potential alternative in management of psoriasis: a review
inferred← citeshttps://doi.org/10.15275/sarmj.2024.0202openalex-snapshot
Advances in dermatology research: A comprehensive literature review
inferred← citeshttps://doi.org/10.15587/2519-4852.2024.299266openalex-snapshot
Assessment of the anti-psoriasis effect of Scrophularia deserti methanolic extract in mice model
inferred← citeshttps://doi.org/10.15789/2220-7619-aot-17910openalex-snapshot
Analysis of the biological diversity of the skin and oropharyngeal microbiota depending on various treatment methods for psoriasis
inferred← citeshttps://doi.org/10.17116/klinderma20262501153openalex-snapshot
Analysis of the use of GEBD in a group of patients with psoriasis (according to the data from the Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology of the Moscow Healthcare Department)
inferred← citeshttps://doi.org/10.21203/rs.3.rs-8234680/v1openalex-snapshot
SYK gain-of-function mutation regulates neutrophil functions to drive spontaneous psoriasis
inferred← citeshttps://doi.org/10.21203/rs.3.rs-8700962/v1openalex-snapshot
Neuroimmune-related differentially expressed genes in psoriasis: A bioinformatics analysis reveals potential biomarkers for diagnosis and treatment
inferred← citeshttps://doi.org/10.2147/ccid.s467442openalex-snapshot
Advancements in Dermatological Applications of Curcumin: Clinical Efficacy and Mechanistic Insights in the Management of Skin Disorders
inferred← citeshttps://doi.org/10.2147/ccid.s511351openalex-snapshot
Cladribine Ameliorates Imiquimod Induced Murine Psoriasiform Dermatitis
inferred← citeshttps://doi.org/10.2147/ccid.s547013openalex-snapshot
Global Research Trends in Apremilast for Psoriasis: A Bibliometric Analysis (2008–2024)
inferred← citeshttps://doi.org/10.2147/ccid.s569278openalex-snapshot
Unsaturated Fatty Acid Metabolic Reprogramming in Psoriatic Skin Drives Inflammation and Predicts Response to Biologic Therapy
inferred← citeshttps://doi.org/10.2147/ccid.s606845openalex-snapshot
Exosomes in Psoriasis: From Pathogenic Mechanisms to Therapeutic Innovations
inferred← citeshttps://doi.org/10.2147/dddt.s504485openalex-snapshot
Tanshinone I Ameliorates Psoriasis-Like Dermatitis by Suppressing Inflammation and Regulating Keratinocyte Differentiation
inferred← citeshttps://doi.org/10.2147/dddt.s520555openalex-snapshot
Therapeutic Potential of Curcumin and Novel Formulations in Psoriasis Treatment: Evidence and Future Prospects
showing the first 200 of 315 · page through all 315
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.